Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
signs and symptoms pathological conditions | D013568 |
Brand Name | Status | Last Update |
---|---|---|
detrol | New Drug Application | 2023-02-15 |
detrol la | New Drug Application | 2023-03-15 |
tolterodine tartarate tolterodine tartrate | ANDA | 2023-03-23 |
tolterodine tartrate | ANDA | 2025-02-07 |
tolterodine tartrate extended release | NDA authorized generic | 2024-12-14 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
urinary incontinence | — | D014549 | R32 |
urinary bladder diseases | — | D001745 | N32.9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | 2 | — | — | 6 | 1 | 9 |
Urinary incontinence | D014549 | — | R32 | — | — | 1 | 5 | — | 6 |
Enuresis | D004775 | — | R32 | — | — | — | 2 | — | 2 |
Memory | D008568 | — | — | — | — | — | 1 | — | 1 |
Cognition | D003071 | EFO_0003925 | — | — | — | — | 1 | — | 1 |
Urinary bladder neck obstruction | D001748 | EFO_1000840 | N32.0 | — | — | — | 1 | — | 1 |
Drug common name | Tolterodine |
INN | tolterodine |
Description | Tolterodine is a tertiary amine. It has a role as a muscarinic antagonist, a muscle relaxant and an antispasmodic drug. It is functionally related to a p-cresol. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1 |
PDB | — |
CAS-ID | 124937-51-5 |
RxCUI | — |
ChEMBL ID | CHEMBL1382 |
ChEBI ID | 9622 |
PubChem CID | 443879 |
DrugBank | DB01036 |
UNII ID | WHE7A56U7K (ChemIDplus, GSRS) |